News & Updates

Show Multimedia Only
New medication available to help Malaysians deal with insomnia
New medication available to help Malaysians deal with insomnia
22 Jun 2023 byPank Jit Sin

A new medication has been approved for the treatment of insomnia. Lemborexant (Dayvigo™, Eisai), is a hypnotic agent belonging to the class of drugs known as dual orexin receptor antagonists (DORAs).

New medication available to help Malaysians deal with insomnia
22 Jun 2023
SGLT2 inhibitors score big, this time in gout
SGLT2 inhibitors score big, this time in gout
22 Jun 2023 byElvira Manzano

Patients initiated on gliflozins or flozins – also called sodium-glucose co-transporter 2 (SGLT2) inhibitors – for type 2 diabetes (T2D) who were previously on metformin had reductions in the incidents of gout of up to 60 percent compared with other second-line agents in a recent study.

SGLT2 inhibitors score big, this time in gout
22 Jun 2023